Cargando…
Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study
BACKGROUND: This post-hoc analysis was conducted to evaluate the effect of erenumab on monthly migraine days, monthly migraine attacks, and attack duration in patients with episodic migraine to investigate whether erenumab actually prevents the occurrence of migraine attacks and/or shortens them. ME...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504413/ https://www.ncbi.nlm.nih.gov/pubmed/33939497 http://dx.doi.org/10.1177/03331024211010308 |